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Results of Testing Fifteen Glycol Ethers in a
Short-Term in Vivo Reproductive Toxicity
Assay
by Ronald L. Schuler,* Bryan D. Hardin,* Richard W. Niemeler,*
Gary Booth,t Keith Hazelden,* Vincent Piccirillo**
and Kirby Smith§
Fifteen glycol ethers were investigated for their potential to cause adverse reproductive toxic effects
using an in vivo mouse screening bioassay. Pregnant mice were orally dosed once per day on days 7 through
14 ofgestation at concentrations causing 0 to41% maternal mortality. Reproductive endpoints included pup
survival in utero (percent of live litters/pregnant survivors), pup perinatal and postnatal survival (number
of live pups per litter, number of dead pups per litter, and pup survival to 2.5 days of age), and pup body
weight statistics (weight at birth and weight at 2.5 days of age).
The studywas conducted intwo phases: adoserange-finding phase usingnonpregnant female mice, and a
definitive reproductive phase using time-mated mice. The range-finding phase sought to identify, for each
chemical, the maternal LD10 as the target dose. However, based upon reproductive phase results, such an
exact dose was impractical to achieve. Thus, a range from the LD5 to the LD20 was considered a sufficient
challenge dose that would not affect results due to high mortality, i.e., greater than the LD20.
Glycol ethers were assigned to groups having different priorities for further testing based upon whethera
sufficient challenge dose was administered and the degree of effects recorded for each chemical. These
groups and chemicals are: (a) very high priority, triethylene glycol dimethyl ether (triEGdiME); (b) high
priority, ethylene glycol (EG), ethylene glycol monomethyl ether (EGME), ethylene glycol monoethyl ether
(EGEE), ethylene glycol diethyl ether (EGdiEE), and diethylene glycol monomethyl ether (diEGME); (c)
middle to high priority, ethylene glycol dimethyl ether (EGdiME) and diethylene glycol dimethyl ether
(diEGdiME); (d) middle priority, ethylene glycol monobutyl ether (EGBE), diethylene glycol (diEG),
diethylene glycol diethyl ether (diEGdiEE) and triethylene glycol (triEG); (e) low priority, diethylene
glycol monoethyl ether (diEGEE) and diethylene glycol dibutyl ether (diEGdiBE). Diethylene glycol
monobutyl ether (diEGBE) was not administered at a sufficient challenge dose and should be repeated.
NIOSH does not regard these results as appropriate for labeling a compound as safe or unsafe. Instead
they are suggestive, when considered along with other information on each chemical, ofthe urgency with
which these chemicals should be considered for more detailed conventional testing.
Introduction
Conventional reproductive testing is expensive, in-
volves complex scheduling, and requires the commit-
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ment of highly trained personnel. These intricate
requirements, coupled with the existence of a large
number of compounds that lack reproductive toxicity
information, have created an urgent need for rapid,
inexpensive methods of screening chemicals for
reproductive toxicity. With this in mind, the National
Institute for Occupational Safety and Health (NIOSH),
in conjunction with the National Toxicology Program
(NTP) in 1981 began to evaluate an in vivo screening
test developed by Chernoff and Kavlock (1). For this
test, pregnant mice are treated during organogenesis
with high doses ofthe test chemicals. Females are then
allowed to deliver their litters and the number of
live-born pups, their birth weight, and growth and
survival to 2 to 3 days of age are monitored. While the
test is not appropriate for labeling a compound as safeSCHULER ET AL.
Table 1. Glycol ethers investigated.
Formula
Glycol Structural Empirical Purity, % Contractorsa
Ethylene glycol (EG) HO-Et-OH C202H6 99+ Inveresk
Ethylene glycol monomethyl ether (EGME) Me-O-Et-OH C302H8 99 Bioassay
Ethylene glycol dimethyl ether (EGdiME) Me-O-Et-O-Me C402H10 99+ MESA
Ethylene glycol monoethyl ether (EGEE) Et-O-Et-OH C402H10 99 Bioassay
Ethylene glycol diethyl ether (EGdiEE) Et-O-Et-O-Et C602H14 95 Borriston
Ethylene glycol monobutyl ether (EGBE) Bu-O-Et-OH C602H14 99 Bioassay
Diethylene glycol (diEG) HO-Et-O-Et-OH C403H10 97 Inveresk
Diethylene glycol monomethyl ether (diEGME) Me-O-Et-O-Et-OH C503H12 99 Bioassay
Diethylene glycol dimethyl ether (diEGdiME) Me-O-Et-O-Et-O-Me C603H14 99 MESA
Diethylene glycol monoethyl ether (diEGEE) Et-O-Et-O-Et-OH C603H14 99+ Borriston
Diethylene glycol diethyl ether (diEGdiEE) Et-O-Et-O-Et-O-Et C803H18 98+ MESA
Diethylene glycol monobutyl ether (diEGBE) Bu-O-Et-O-Et-OH C803H18 99+ Borriston
Diethylene glycol dibutyl ether (diEGdiBE) Bu-O-Et-O-Et-O-Bu C1203H26 99+ Inveresk
Triethylene glycol (triEG) HO-Et-O-Et-O-Et-OH C604H14 99 Borriston
Triethylene glycol dimethyl ether (triEGdiME) Me-O-Et-O-Et-O-Et-O-Me C804H18 99 MESA
aBiossay = Bioassay Systems Corporation, 225 Wildwood Avenue, Woburn, MA 01801; Borriston = Borriston Laboratories, Incorporated,
5050 Beech Place, Temple Hills, MD 20748; Inveresk = Inveresk Research International Limited, Edinburgh EH21 7UB, Scotland; MESA =
Minority Enterprise Service Associates, 1156 South State, Orem, UT 84057.
or unsafe, it may serve to generate data useful in
establishing priorities for conventional testing. It may
also be useful for rapidly surveying structure-activity
relationships. As part ofthe NTP evaluationofpotential
reproductive toxins, four contracts were awarded by
NIOSH underwhich atotal of30 chemicals were tested.
Fifteen of the chemicals were glycols or glycol ethers
and the results of those tests are summarized here. Of
these 15, three contractors tested 4 chemicals each and
one contractor tested the remaining 3 (see Table 1).
None were tested in more than one laboratory.
Methods
All contractors used CD-1 mice purchased from
Charles RiverBreedingLaboratories, Inc. (Wilmington,
MA) throughout these studies. Chemicals were eval-
uated in two phases: a preliminary dose-finding study in
nonpregnant mice followed by the reproductive phase
using time-mated females. In both phases chemicals
were evaluated in blocks oftwo to four chemicals with a
shared concurrent vehicle control group. Some blocks
included only glycols, others included other chemicals.
Only data on glycols are reported here. Chemicals were
provided to contractors by NIOSH and were tested in
blind, with the chemicals identified by an arbitrary code
number. Table 1 summarizes the glycolstested and their
abbreviations, structural formulas, chemical purity and
the laboratories that performed the investigations.
diEGdiBE was administered in corn oil due to its
insolubility in water. Distilled water served as the
vehicle for all other glycols tested. Dosage was by oral
gavage in all instances.
The dose range-findingstudy was conducted at 5 dose
levels using ten mice, 6 to 8 weeks old, per treated or
control group (except for diEGBE and diEGdiEE
where the mice were 60 to 80 days old*). Upon receipt,
mice were weighed and marked for individual identifi-
cation, then formally randomized to treatment groups.
Mice were group-housed, five per cage, throughout the
range-finding study. Standard laboratory rodent chow
and untreated tap water were available ad libitum.
Bedding of a type known not to induce microsomal
enzymes was changed as needed or at least once per
week. Oral doses were administered once daily for 8
consecutive days using a constant dose volume of 10
mL/kg body weight. Body weights were recorded on
days 1 and 8 ofthe dosing period and on days 4 and 8 of
an 8-day post-dosing observation period. Group mean
or individual body weights taken on the first day of
dosing were used to calculate treatment volumes over
the entire 8-daydosingperiod. Survivors were sacrificed
immediately following the last weighing on the 8th
post-dosing day. All mice that died before that time
were necropsied for evidence ofdosing error as a cause
of death. Based on the results of these dose-finding
studies, the estimated LD10 dose was selected for the
reproductive phase.
Reproductive studies were conducted in time-mated
CD-1 mice, 6 to 8 weeks ofage, orally dosed on days 7 to
14 ofgestation (day 1 ofgestation is the day on which a
copulatory plug is observed). Mice were received on or
before day 5 of gestation. On day 5 they were weighed
and marked for individual identification, then formally
randomized to treatment or control groups of 50 mice
each. Test chemicals were administered at a single dose
in aconstant volume of10mL/kgbodyweight. Maternal
*Because ofthe demand placed upon the single animal supplier by
all four contractors, the initial requirement to use 60- to 80-day-old
mice was changed. This change required the use ofthe more readily
available 6- to 8-week-old mice.
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body weights were taken on day 7 of gestation
immediately before dosing, on day 18 of gestation, and
on day 3 postpartum. The weight of the animal on
gestation day 7 was used to calculate the dosage for the
entire period. All mice were housed individually
throughout the reproductive study. Food, water and
bedding were provided as in the range-finding studies
except bedding was not changed after gestation day 18.
Females were observed with minimal disturbances
twice daily beginning on day 18 ofgestation. As soon as
possible after litters were delivered (within 12 hr), the
number of live and stillborn pups was recorded.
Maternal body weight was recorded and all live pups
were weighed together. Pups and their dams were then
returned to nest boxes and were left undisturbed until
48 hr after the initial weighing, at which time the
number of live pups, their total weight, and maternal
body weight were again recorded.
Details of the statistical analyses varied from one
contractor to another, but generally the procedures
were similar. Body weight data were analyzed by
analysis of variance. The proportion of surviving
pregnant mice that gave birth to viable litters (one or
more live-born pups) was evaluated by the Fisher-Irwin
exact test. Numbers of live and stillborn pups and
percent survival to 2.5 days of age were analyzed by
analysis of variance and the Student's t-test.
Results
Tables 2 and 3 present the findings of the postnatal
screen ofthe 15 glycol ethers. Because these chemicals
were investigated by four independent laboratories at
different times and in some cases concurrently with
other chemicals, seven control groups were used (some
controls served more than one chemical). Control values
were generally consistent across these seven groups.
There was only one maternal death in all control groups
and that was a result of a gavage error. Reproductive
success in the controls ranged from 91 to 100% of all
pregnant survivors. The average litter size ranged from
9 to 11 pups per litter. The percent pup postnatal
survival (to 2.5 days postpartum) ranged from 98 to
100%. The average pup weight gain over days 1 to 3
postpartum ranged from 0.4 g to 1.1 g, and the average
pup birth weight ranged from 1.6 g to 1.7 g.
Nine offifteen glycols tested affected the viable litter
index. Pregnant mice treated with EGME, EGEE,
EGdiME, diEGdiME, and triEGdiME produced no
viable litters. Mice treated with EG, EGBE, EGdiEE
Table 2. Glycol ether results: maternal mortality and pregnancy success.
Maternal Viable Dose mortality litters
Block Glycol mmole/kg mg/kg (%)a (%)b
A Control 0/50 ( 0) 31/32 ( 97)
EGME 18.4 1400 7/49 (14) 0/30 ( 0)
EGEE 40.1 3605 5/50 (10) 0/32* ( 0)
EGBE 10.0 1180 10/50 (20) 24/31* ( 77)
diEGME 33.3 4000 5/50 (10) 5/32* (16)
B Control 0/49 ( 0) 30/31 ( 97)
diEGBE 3.1 500 0/50 ( 0) 36/37 ( 97)
C Control 0/50 ( 0) 42/42 (100)
EGdiEE 25.0 2955 5/50 (10) 4/35* (11)
diEGEE 41.0 5500 7/50 (14) 32/33 ( 97)
triEGC 75.1 11270 2/50 ( 4) 36/36 (100)
D Control 0/50 ( 0) 29/29 (100)
EGC 178.9 11090 5/50 (10) 15/37* ( 41)
diEGc 105.5 11180 2/50 ( 4) 33/36 ( 92)
E Controld 0/50 ( 0) 45/45 (100)
diEGdiBEd 9.2 2000 4/50 ( 8) 38/40 ( 95)
F Control 0/50 ( 0) 41/45 ( 91)
diEGdiEE 18.5 3000 0/40 ( 0) 35/41 ( 85)
G Control 0/50 ( 0) 42/43 ( 98)
EGdiME 22.2 2000 13/50 (26) 0/34* ( 0)
diEGdiME 22.4 3000 20/49 (41) 0/27* ( 0)
triEGdiME 19.7 3500 2/50 ( 4) 0/37* ( 0)
arfreatment-related deaths/number on test (percent mortality).
bLitters with one or more live-born pups/number of pregnant survivors (percent of pregnancies).
'Administered without dilution in volume of 10 mL/kg.
dCorn oil used as the vehicle; all other groups used distilled water vehicle.
*Differs significantly (p < 0.05) from concurrent control by Fisher's exact test.
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Table 3. Neonatal observations.
No. No. Pup
Dose live pups dead pups Pup weight gain per litter per litter postnatal over days 1-3 Pup birth
Block Glycol mmole/kg mg/kg at birth at birth survival (%) post partum, g weight, g
A Control 10 0.1 100 0.4 1.6
EGME 18.4 1400 No litters
EGEE 40.1 3605 No litters
EGBE 10.0 1180 10 0.2 95 0.4 1.5
diEGME 33.3 4000 3 0.6 31* 0.5 1.4
B Control 10 0 99 1.1 1.6
diEGBE 3.1 500 10 0 99 1.1 1.6
C Control 10 0 99 0.9 1.6
EGdiEE 25.0 2955 1t 2t 451 0.61 1.31
diEGEE 41.0 5500 10 0 98 0.9 1.5t
triEG 75.1 11270 9 0 99 1.0 1.5t
D Control 9 0.1 100 0.7 1.7
EG 178.9 11090 2t 1.5t 40t 0.2t 1.4t
diEG 105.5 11180 10 0.2 97 0.6t 1.6
E Control 11 0 100 0.6 1.7
diEGdiBE 9.2 2000 11 0.2t 100 0.6 1.7
F Control 10 0.1 98 0.5 1.6
diEGdiEE 18.5 3000 10 0.4 97 0.5 1.5*
G Control 10 0.3 98 0.7 1.6
EGdiME 22.2 2000 No litters
diEGdiME 22.4 3000 No litters
triEGdiME 19.7 3500 No litters
*Significantly different (p < 0.05) from concurrent control by analysis of variance.
*Not tested statistically due to small sample size.
tSignificantly different (p < 0.05) from concurrent control by Student's t-test.
and diEGME showed a significant reduction (p < 0.05)
in viable litters produced (41, 77, 11, and 16 percent
viable litters produced, respectively). The remaining
glycols and glycol ethers produced no effect on that
reproductive index at the concentrations administered.
Postnatal observations varied widely in those groups
with viable litters. EG and EGdiEE reduced the
number oflive pups per litter, increased the number of
dead pups per litter, reduced pup survival, reduced pup
birth weight and reduced pup weight gain over days 1 to
3 postpartum. EGdiEE data were not analyzed statisti-
cally because of the small sample size. diEGME
significantly reduced (p < 0.05) the number oflive pUps
per litter and pup survival over days 1 to 3 postpartum.
diEGdiEE significantly increased (p < 0.05) the number
of dead pups per litter and significantly reduced (p <
0.05) pup birth weight. diEGdiBE increased (p < 0.05)
the number of dead pups per litter. diEG reduced (p <
0.05) pup weight gain over day 1 to 3 postpartum and
triEG and diEGEE reduced (p < 0.05) mean pup birth
weight.
Discussion
Because it is our intent to use this bioassay to screen
chemicals for their potential to cause reproductive
toxicity in pregnant females, it is necessary to employ
clearly toxic doses. If a chemical is evaluated as a low
priority, one wants to be relatively confident that it was
tested at a sufficiently severe challenge level. Clear
maternal toxicity does not mean that reproductive
toxicity follows. diEG and triEG produced 4% maternal
mortality; diEGdiBE produced 8% mortality; and
diEGEE produced 14%mortality. None ofthese showed
strong evidence of reproductive toxicity. In fact,
diEGEE treatment did not adversely affect any of the
reproductive indices.
As noted, the estimated maternal LD10 was chosen as
the challenge dose to be used for the reproductive
studies. In practice, mortality will vary somewhat, and
a response in the LD520 range was considered
acceptable in the reproductive phase. If reproductive
effects are noted in the presence of more than 20%
maternalmortality, thetestprobablyshouldberepeated
at a lower dose. Conversely, if there is no reproductive
toxicity and less than 5% maternal mortality, the test
probably should be repeated at a higher dose. This
LD=20 range, however, is only a tentative suggestion
and furtherexperience with this test may suggest other
criteria forjudging the appropriateness ofthe challenge
dose.
The six end points examined for determining the
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priority of chemicals for further testing can be
condensed into three levels of consideration. Most
important is pup survival in utero, i.e., percent viable
litters delivered by pregnant survivors. Of second
importance is pup perinatal and postnatal survival, i.e.,
the number oflive and dead pups per litterat birth, and
pup survival over days 1 to 3 post partum. Final
consideration is given to pup body weight end points,
i.e., pup weight gain over days 1 to 3 and pup weight at
birth.
Chemicals were assigned to groups having different
priorities for further testing, based upon whether a
sufficient dose was administered (the maternal LD520)
and the degree of effects recorded for each chemical.
triEGdiME therefore has a very high priority for
further testing because the administered dose of 4%
maternal mortality was less than the LD!20, and the
results were profound, i.e., no viable litters delivered.
Other chemicals deserving high priority include EG,
EGME, EGEE, EGdiEE, and diEGME in that all were
tested within the range of 5 to 20% maternal mortality
and all showed a drastic reduction of viable litters. A
middle to high level priority group would include
EGdiME and diEGdiME because both produced no
viable litters but they received a dose greater than the
LD520 which could have influenced the results due to
maternal toxicity effects. A middle level priority group
would include EGBE, diEG, diEGdiEE and triEG.
EGBE significantly reduced viable litters with no other
effects when dosed at the upper limit of the range of
acceptable mortality. diEG, diEGdiEE and triEG mice
received less than the LD520 dose but still produced
some lesser effects: reduced pup weight gain for diEG;
reduced pup weight gain and decreased number of live
pups per litter for triEG; and an increased number of
dead pups per litter plus a reduced pup birth weight for
diEGdiEE. Alowpriority groupwould include diEGEE
and diEGdiBE because the LD=20 dose was achieved
and only lesser effects were seen, i.e., a reduced pup
birth weight for diEGEE and an increased number of
dead pups per litter for diEGdiBE. diEGBE mice did
not receive a maternally toxic dose and no effects were
found, thus diEGBE should be repeated until an
LD.20 dose is achieved.
It is important to note that, for the purposes of this
screen, comparisons among chemicals are based upon
maternal mortality, i.e., doses less than, greater than,
or within the LD,20 range. Comparisons as to the
potential exposure hazard are not made. For example,
although EG is designated to a higher priority group
than EGBE, it may be that an individual is more likely
to receive an 1180 mg/kg dose ofEGBE (LD20) than he
is to receive an 11,090 mg/kg dose of EG (LDIo). Thus
EGBE may be more of a potential hazard than EG.
Previous investigations have shown several of the
glycol ethers assessed in the current work to be
teratogenic in traditional teratology test systems.
EGME (designated in our high priority group) induced
skeletal anomalies in the offspring ofmice receiving, by
oral gavage, as low as 31 mg/kg/day over days 7 through
14 of gestation (2). Gross (external) anomalies and the
incidence of embryonic death were greatly increased in
the offspring of mice receiving 250 mg/kg/day. In an
inhalation study, 200 ppm EGME for 7 hr/day on
gestation days 7 through 15 caused complete embryonic
death in rats (3). Reduced fetal weights, skeletal and
cardiovascular defects, as well as increased embryonic
death occurred at both 50 and 100 ppm.
EGEE, also in the high priority group, induced
skeletal anomalies, increased embryonic death, and
decreased pup weightinoffspring ofrats treatedby oral
gavage on days 1 through 21 of gestation (4). Doses
ranged from 12 to 327 mg/kg/day. Inhalation of 160 ppm
EGEE for 7 hr/day on days 1 through 18 of gestation
increased embryonic death and skeletal anomalies in
rabbits (5). At 615 ppm complete embryonic death
occurred. Offspringofrats receivinga 1.0mL or2.0 mL
dermal application of EGEE on days 7 through 16 of
gestation showed greatly increased embryonic deaths,
and cardiovascular and skeletal anomalies (2). Offspring
ofrats receiving 100 ppm ofEGEE for 7 hr/day on days
7 through 13 or 14 through 20 of gestation showed
altered behavioral patterns and altered brain neuro-
chemical concentrations (7).
EGdiME, placed in our middle to high level priority
group, administered to pregnant mice by oral gavage on
days 7 through 10 of gestation caused increased
embryonic death at concentrations of250, 350, and 490
mg/kg/day (8). Skeletal and external anomalies occurred
in the 490 mg/kg group. EGBE, in our middle priority
group, caused no apparent adverse effect on the
offspring ofrats exposed to 200 ppm EGBE for 7 hr/day
on gestation days 7 through 15 (3). diEGEE, in our low
prioritygroup, caused no adverse effect onthe offspring
of rats exposed to 100 ppm for 7 hr/day on days 7
through 15 of gestation (3).
Some general statements can be made regarding
structure-activity relationships. All mice receiving
glycol ethers having terminal methyl groups, i.e.,
EGME, EGdiME, diEGME, diEGdiME andtriEGdiME
produced few viable litters (0, 0, 16, 0, and 0%,
respectively). Only EGEE and EGdiEE having ter-
minal ethyl groups produced similar results (0 and 11%
viable litters, respectively). The remaining ethyl ethers
(diEGEE and diEGdiEE), the butyl ethers (EGBE,
diEGBE, diEGdiBE), and the glycol ethers with ter-
minal hydroxy groups (EG, diEG and triEG) did not
produce such profound fetotoxicity. Maternal toxicity of
the glycols was sharply increased by the addition of an
alkyl group. EGBE was more toxic than EGME which
was more toxic than EGEE. All three showed greater
toxicity than EG. The diEG mono-and diEGdi-alkyl
ethers were more toxic than diEG, and triEGdiME was
more toxic than triEG. The methyl ethers were gener-
ally more toxic than the ethyl or butyl ethers with the
exception of EGBE.
We would caution again that neither NIOSH nor the
NTP regards these results as definitive. Instead, they
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are suggestive, when considered along with other
information on each chemical, of the urgency with
which these chemicals should be considered for more
detailed conventional testing. From the current avail-
able information on the glycol ethers, a correlation can
be seenbetweentheknownpositive teratogens (EGME,
EGEE, and EGdiME) and their results in this in vivo
screen where these compounds were designated either
in a high priority ormiddle to high priority group. Also,
EGBE and diEGEE, which showed no reproductive
toxicity in conventional tests, were given a lower
priority ranking (middle or low group) following testing
in this screen.
The authors wish to express their appreciation to Sandra Clark
(NIOSH) for the excellent typing of this manuscript.
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